Investigating interferences of a whole-blood point-of-care creatinine analyzer: Comparison to plasma enzymatic and definitive creatinine methods in an acute-care setting

Clinical Chemistry

Volumn 57, Issue 11, 2011, Pages 1566-1573

  Straseski, Joely A ^a   Lyon, Martha E ^b,e   Clarke, William ^c   DuBois, Jeffrey A ^d   Phelan, Lois A ^c   Lyon, Andrew W ^b  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; CREATINE; CREATININE; OXYGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD ANALYSIS; BLOOD OXYGEN TENSION; BLOOD PH; BLOOD SAMPLING; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ENZYME ASSAY; FEMALE; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HOSPITAL PATIENT; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; ISOTOPE DILUTION ASSAY; ISOTOPE DILUTION MASS SPECTROMETRY ASSAY; KIDNEY FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PLASMA WATER FRACTION; POINT OF CARE TESTING; RED BLOOD CELL WATER FRACTION;

CREATININE; ENZYMES; FALSE NEGATIVE REACTIONS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; INDICATOR DILUTION TECHNIQUES; INDICATORS AND REAGENTS; INPATIENTS; INTENSIVE CARE UNITS; KIDNEY DISEASES; LINEAR MODELS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MULTIVARIATE ANALYSIS; ONCOLOGY SERVICE, HOSPITAL; POINT-OF-CARE SYSTEMS; REFERENCE STANDARDS;

EID: 80055076954     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2011.165480     Document Type: Article

References (26)

1. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
2. Schweiger MJ, Chambers CE, Davidson CJ, Blankenship J, Bhalla NP, Block PC, et al. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007;69:135-40. (Pubitemid 46052605)
3. Fogh-Andersen N, Wimberley PD, Thode J, Siggaard-Andersen O. Direct reading glucose electrodes detect the molality of glucose in plasma and whole blood. Clin Chim Acta 1990; 189:33-8. (Pubitemid 20185587)
4. Burnett RW, D'Orazio P, Fogh-Andersen N, Kuwa K, Kulpmann WR, Larsson L, et al. IFCC recommendation on reporting results for blood glucose. Clin Chim Acta 2001;307:205-9. (Pubitemid 32448926)
5. Lyon ME, Gray D, Baskin LB, Dubois JA, Lyon AW. A mathematical model to assess the influence of hematocrit on point of care glucose meter performance. Clin Biochem 2010;43:905-9.
6. Lyon ME, Baskin LB, Braakman S, Presti S, Dubois J, Shirey T. Interference studies with two hospitalgrade and two home-grade glucose meters. Diabetes Tech Ther 2009;11:641-7.
7. Lyon ME, Lyon AW. Patient acuity exacerbates discrepancy between whole blood and plasma methods through bias and variance in molality to molarity conversion: "Mind the gap!" Clin Biochem 2011;44:412-7.
8. Harlan R, Clarke W, Di Bussolo JM, Kozak M, Straseski J, Meany DL. An automated turbulent flow liquid chromatography-isotope dilution mass spectrometry (LC-IDMS) method for quantitation of serum creatinine. Clin Chim Acta 2010;411: 1728-34.
9. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766-72. (Pubitemid 46580250)
10. Myers GL, Miller WG, Coresh J, Fleming J, Greenberg N, Greene T, et al. Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the National Kidney Disease Education Program. Clin Chem 2006;52:5-18. (Pubitemid 43032461)
11. Haeckel R, Hanecke P. Problems of comparing blood glucose molality and molarity determined with an Omni, an EML 105 and an Ebio analyser. Clin Chem Lab Med 2003;41:950-7. (Pubitemid 37010191)
12. Lew VL, Freeman CJ, Ortiz OE, Bookchin RM. A mathematical model of the volume, pH, and ion content regulation in reticulocytes: application to the pathophysiology of sickle cell dehydration. J Clin Invest 1991;87:100-12.
13. DeMoll E, Cox DJ, Daniel E, Riggs AF. Apparent specific volume of human hemoglobin: effect of ligand state and contribution of heme. Anal Biochem 2007;363:196-203. (Pubitemid 46437320)
14. McCullough PA. Contrast-induced acute kidney injury. J Am Coll Cardiol 2008;51:1419 -28.
15. Nichols JH, Bartholomew C, Bonzagi A, Garb JL, Jin L. Evaluation of the IRMA TRUpoint and i-STAT creatinine assays. Clin Chim Acta 2007; 377:201-5. (Pubitemid 44908252)
16. Flegar-Mestric Z, Perkov S. Comparability of point-of-care whole-blood electrolyte and substrate testing using a Stat Profile Critical Care Xpress analyzer and standard laboratory methods. Clin Chem Lab Med 2006;44:898-903.
17. Udy A, O'Donoghue S, D'Intini V, Healy H, Lipman J. Point of care measurement of plasma creatinine in critically ill patients with acute kidney injury. Anaesthesia 2009;64:403-7.
18. Schenk PW, Cransberg K, Wolff ED, de Rijke YB. Point-of-care creatinine testing in children at risk for sudden deterioration of renal function. Clin Chem Lab Med 2007;45:1536-41. (Pubitemid 350036569)
19. Kost GJ, Vu HT, Inn M, DuPlantier R, Fleisher M, Kroll MH, Spinosa JC. Multicenter study of wholeblood creatinine, total carbon dioxide content, and chemistry profiling for laboratory and pointof- care testing in critical care in the United States. Crit Care Med 2000;28:2379-89. (Pubitemid 30604443)
20. Kampa IS, Keffer P. The use of a whole-blood benchtop analyzer (Nova 16) in a cardiac stat intensive care unit. Clin Chem 1998;44:884 -5.
21. Papadea C, Foster J, Grant S, Ballard SA, Cate JCt, Southgate WM, Purohit DM. Evaluation of the i-STAT Portable Clinical Analyzer for point-ofcare blood testing in the intensive care units of a university children's hospital. Ann Clin Lab Sci 2002;32:231-43. (Pubitemid 34840122)
22. Korpi-Steiner NL, Williamson EE, Karon BS. Comparison of three whole blood creatinine methods for estimation of glomerular filtration rate before radiographic contrast administration. Am J Clin Pathol 2009;132:920-6.
23. Aumatell A, Sharpe D, Reed W. Validation of the StatSensor Creatinine meter for testing blood before contrast computed tomography studies. Point Care 2010;9:25-31.
24. Shephard M, Peake M, Corso O, Shephard A, Mazzachi B, Spaeth B, et al. Assessment of the Nova StatSensor whole blood point-of-care creatinine analyzer for the measurement of kidney function in screening for chronic kidney disease. Clin Chem Lab Med 2010;48:1113-9.
25. Schnabl KL, Bagherpoor S, Diker P, Cursio C, Dubois J, Yip PM. Evaluation of the analytical performance of the Nova StatSensor creatinine meter and reagent strip technology for whole blood testing. Clin Biochem 2010;43:1026-9.
26. Schneditz D, Yang Y, Christopoulos G, Kellner J. Rate of creatinine equilibration in whole blood. Hemodial Int 2009;13:215-21.